B-Symptom	0	10	Peripheral
I-Symptom	11	18	lesions
O	19	29	identified
O	30	32	by
B-Diagnostic_tool	33	42	mydriatic
I-Diagnostic_tool	43	52	ultrawide
I-Diagnostic_tool	53	58	field
I-Diagnostic_tool	59	66	imaging
O	66	67	:
O	68	80	distribution
O	81	84	and
O	85	94	potential
O	95	101	impact
O	102	104	on
B-Disease	105	113	diabetic
I-Disease	114	125	retinopathy
O	126	134	severity
O	134	135	.

O	137	139	To
O	140	146	assess
B-Disease	147	155	diabetic
I-Disease	156	167	retinopathy
O	168	169	(
B-Disease	169	171	DR
O	171	172	)
O	173	175	as
O	176	186	determined
O	187	189	by
O	190	197	lesions
O	198	208	identified
O	209	214	using
B-Diagnostic_tool	215	224	mydriatic
I-Diagnostic_tool	225	234	ultrawide
I-Diagnostic_tool	235	240	field
I-Diagnostic_tool	241	248	imaging
O	249	250	(
B-Diagnostic_tool	250	258	DiSLO200
O	258	259	;
O	260	265	Optos
O	266	269	plc
O	269	270	,
O	271	279	Scotland
O	279	280	,
O	281	283	UK
O	283	284	)
O	285	293	compared
O	294	298	with
B-Diagnostic_tool	299	304	Early
I-Diagnostic_tool	305	314	Treatment
I-Diagnostic_tool	315	323	Diabetic
I-Diagnostic_tool	324	335	Retinopathy
I-Diagnostic_tool	336	341	Study
I-Diagnostic_tool	342	343	(
I-Diagnostic_tool	343	348	ETDRS
I-Diagnostic_tool	348	349	)
I-Diagnostic_tool	350	351	7
I-Diagnostic_tool	351	352	-
I-Diagnostic_tool	352	360	standard
I-Diagnostic_tool	361	366	field
I-Diagnostic_tool	367	371	film
I-Diagnostic_tool	372	383	photography
O	383	384	.

O	385	396	Prospective
O	397	408	comparative
O	409	414	study
O	415	417	of
B-Diagnostic_tool	418	426	DiSLO200
O	426	427	,
B-Diagnostic_tool	428	433	ETDRS
I-Diagnostic_tool	434	435	7
I-Diagnostic_tool	435	436	-
I-Diagnostic_tool	436	444	standard
I-Diagnostic_tool	445	450	field
I-Diagnostic_tool	451	455	film
I-Diagnostic_tool	456	467	photographs
O	467	468	,
O	469	472	and
B-Diagnostic_tool	473	480	dilated
I-Diagnostic_tool	481	487	fundus
I-Diagnostic_tool	488	499	examination
O	500	501	(
B-Diagnostic_tool	501	504	DFE
O	504	505	)
O	505	506	.

O	507	508	A
O	509	514	total
O	515	517	of
O	518	521	206
B-Anatomy	522	526	eyes
O	527	529	of
O	530	533	103
B-Disease	534	542	diabetic
O	543	551	patients
O	552	560	selected
O	561	563	to
O	564	573	represent
O	574	577	all
O	578	584	levels
O	585	587	of
B-Disease	588	590	DR
O	590	591	.

O	592	600	Subjects
O	601	604	had
B-Diagnostic_tool	605	613	DiSLO200
O	613	614	,
B-Diagnostic_tool	615	620	ETDRS
I-Diagnostic_tool	621	622	7
I-Diagnostic_tool	622	623	-
I-Diagnostic_tool	623	631	standard
I-Diagnostic_tool	632	637	field
I-Diagnostic_tool	638	642	film
I-Diagnostic_tool	643	654	photographs
O	654	655	,
O	656	659	and
B-Diagnostic_tool	660	663	DFE
O	663	664	.

O	665	671	Images
O	672	676	were
O	677	683	graded
O	684	687	for
O	688	696	severity
O	697	700	and
O	701	713	distribution
O	714	716	of
B-Symptom	717	719	DR
I-Symptom	720	727	lesions
O	727	728	.

O	729	742	Discrepancies
O	743	747	were
O	748	759	adjudicated
O	759	760	,
O	761	764	and
O	765	771	images
O	772	776	were
O	777	785	compared
O	786	790	side
O	791	793	by
O	794	798	side
O	798	799	.

O	800	812	Distribution
O	813	815	of
B-Symptom	816	826	hemorrhage
I-Symptom	827	830	and
I-Symptom	830	831	/
I-Symptom	831	833	or
I-Symptom	834	847	microaneurysm
O	848	849	(
B-Symptom	849	850	H
I-Symptom	850	851	/
I-Symptom	851	853	Ma
O	853	854	)
O	854	855	,
B-Symptom	856	862	venous
I-Symptom	863	870	beading
O	871	872	(
B-Symptom	872	874	VB
O	874	875	)
O	875	876	,
B-Symptom	877	889	intraretinal
I-Symptom	890	903	microvascular
I-Symptom	904	915	abnormality
O	916	917	(
B-Symptom	917	921	IRMA
O	921	922	)
O	922	923	,
O	924	927	and
B-Symptom	928	931	new
I-Symptom	932	939	vessels
I-Symptom	940	949	elsewhere
O	950	951	(
B-Symptom	951	954	NVE
O	954	955	)
O	955	956	.

O	957	962	Kappa
O	963	964	(
O	964	965	κ
O	965	966	)
O	967	970	and
O	971	979	weighted
O	980	981	κ
O	982	992	statistics
O	993	996	for
O	997	1006	agreement
O	1006	1007	.

O	1008	1011	The
O	1012	1024	distribution
O	1025	1027	of
B-Disease	1028	1030	DR
O	1031	1039	severity
O	1040	1042	by
B-Diagnostic_tool	1043	1048	ETDRS
I-Diagnostic_tool	1049	1050	7
I-Diagnostic_tool	1050	1051	-
I-Diagnostic_tool	1051	1059	standard
I-Diagnostic_tool	1060	1065	field
I-Diagnostic_tool	1066	1070	film
I-Diagnostic_tool	1071	1082	photographs
O	1083	1086	was
B-Characteristic	1087	1089	no
I-Characteristic	1090	1092	DR
O	1093	1095	12
O	1095	1096	.
O	1096	1097	5
O	1097	1098	%
O	1098	1099	;
B-Disease	1100	1116	nonproliferative
I-Disease	1117	1119	DR
O	1120	1124	mild
O	1125	1127	22
O	1127	1128	.
O	1128	1129	5
O	1129	1130	%
O	1130	1131	,
B-Disease	1132	1140	moderate
O	1141	1143	30
O	1143	1144	%
O	1144	1145	,
O	1146	1149	and
B-Disease	1150	1156	severe
I-Disease	1156	1157	/
I-Disease	1157	1161	very
I-Disease	1162	1168	severe
O	1169	1170	8
O	1170	1171	%
O	1171	1172	;
O	1173	1176	and
B-Disease	1177	1190	proliferative
I-Disease	1191	1193	DR
O	1194	1196	27
O	1196	1197	%
O	1197	1198	.

B-Disease	1199	1207	Diabetic
I-Disease	1208	1219	retinopathy
O	1220	1228	severity
O	1229	1236	between
B-Diagnostic_tool	1237	1245	DiSLO200
O	1246	1249	and
B-Diagnostic_tool	1250	1255	ETDRS
I-Diagnostic_tool	1256	1260	film
I-Diagnostic_tool	1261	1272	photographs
O	1273	1280	matched
O	1281	1283	in
O	1284	1286	80
O	1286	1287	%
O	1288	1290	of
B-Anatomy	1291	1295	eyes
O	1296	1297	(
O	1297	1305	weighted
O	1306	1307	κ
O	1308	1309	=
O	1310	1311	0
O	1311	1312	.
O	1312	1314	74
O	1314	1315	,
O	1315	1316	κ
O	1317	1318	=
O	1319	1320	0
O	1320	1321	.
O	1321	1323	84
O	1323	1324	)
O	1325	1328	and
O	1329	1332	was
O	1333	1339	within
O	1340	1341	1
O	1342	1347	level
O	1348	1350	in
O	1351	1353	94
O	1353	1354	.
O	1354	1355	5
O	1355	1356	%
O	1357	1359	of
B-Anatomy	1360	1364	eyes
O	1364	1365	.

B-Diagnostic_tool	1366	1374	DiSLO200
O	1375	1378	and
B-Diagnostic_tool	1379	1382	DFE
O	1383	1390	matched
O	1391	1393	in
O	1394	1396	58
O	1396	1397	.
O	1397	1398	8
O	1398	1399	%
O	1400	1402	of
B-Anatomy	1403	1407	eyes
O	1408	1409	(
O	1409	1417	weighted
O	1418	1419	κ
O	1420	1421	=
O	1422	1423	0
O	1423	1424	.
O	1424	1426	69
O	1426	1427	,
O	1427	1428	κ
O	1429	1430	=
O	1431	1432	0
O	1432	1433	.
O	1433	1435	47
O	1435	1436	)
O	1437	1440	and
O	1441	1445	were
O	1446	1452	within
O	1453	1454	1
O	1455	1460	level
O	1461	1463	in
O	1464	1466	91
O	1466	1467	.
O	1467	1468	2
O	1468	1469	%
O	1470	1472	of
B-Anatomy	1473	1477	eyes
O	1477	1478	.

O	1479	1484	Forty
B-Anatomy	1485	1489	eyes
O	1490	1491	(
O	1491	1493	20
O	1493	1494	%
O	1494	1495	)
O	1496	1499	had
B-Disease	1500	1502	DR
O	1503	1511	severity
O	1512	1525	discrepancies
O	1526	1533	between
B-Diagnostic_tool	1534	1542	DiSLO200
O	1543	1546	and
B-Diagnostic_tool	1547	1552	ETDRS
I-Diagnostic_tool	1553	1557	film
I-Diagnostic_tool	1558	1569	photographs
O	1569	1570	.

O	1571	1574	The
B-Symptom	1575	1582	retinal
I-Symptom	1583	1590	lesions
O	1591	1598	causing
O	1599	1612	discrepancies
O	1613	1617	were
B-Symptom	1618	1619	H
I-Symptom	1619	1620	/
I-Symptom	1620	1622	Ma
O	1623	1625	52
O	1625	1626	%
O	1626	1627	,
B-Symptom	1628	1632	IRMA
O	1633	1635	26
O	1635	1636	%
O	1636	1637	,
B-Symptom	1638	1641	NVE
O	1642	1644	17
O	1644	1645	%
O	1645	1646	,
O	1647	1650	and
B-Symptom	1651	1653	VB
O	1654	1655	4
O	1655	1656	%
O	1656	1657	.

O	1658	1671	Approximately
O	1672	1675	one
O	1675	1676	-
O	1676	1681	third
O	1682	1684	of
B-Symptom	1685	1686	H
I-Symptom	1686	1687	/
I-Symptom	1687	1689	Ma
O	1689	1690	,
B-Symptom	1691	1695	IRMA
O	1695	1696	,
O	1697	1700	and
B-Symptom	1701	1704	NVE
O	1705	1709	were
O	1710	1723	predominantly
O	1724	1731	outside
O	1732	1737	ETDRS
O	1738	1744	fields
O	1744	1745	.

O	1746	1753	Lesions
O	1754	1764	identified
O	1765	1767	on
B-Diagnostic_tool	1768	1776	DiSLO200
O	1777	1780	but
O	1781	1784	not
B-Diagnostic_tool	1785	1790	ETDRS
I-Diagnostic_tool	1791	1795	film
I-Diagnostic_tool	1796	1807	photographs
O	1808	1817	suggested
O	1818	1819	a
O	1820	1824	more
O	1825	1831	severe
B-Disease	1832	1834	DR
O	1835	1840	level
O	1841	1843	in
O	1844	1846	10
O	1846	1847	%
O	1848	1850	of
B-Anatomy	1851	1855	eyes
O	1855	1856	.

O	1857	1869	Distribution
O	1870	1872	in
O	1873	1876	the
B-Anatomy	1877	1885	temporal
I-Anatomy	1885	1886	,
I-Anatomy	1887	1901	superotemporal
I-Anatomy	1901	1902	,
I-Anatomy	1903	1917	inferotemporal
I-Anatomy	1917	1918	,
I-Anatomy	1919	1930	superonasal
I-Anatomy	1930	1931	,
I-Anatomy	1932	1935	and
I-Anatomy	1936	1947	inferonasal
I-Anatomy	1948	1954	fields
O	1955	1958	was
O	1959	1961	77
O	1961	1962	%
O	1962	1963	,
O	1964	1966	72
O	1966	1967	%
O	1967	1968	,
O	1969	1971	61
O	1971	1972	%
O	1972	1973	,
O	1974	1976	65
O	1976	1977	%
O	1977	1978	,
O	1979	1982	and
O	1983	1985	59
O	1985	1986	%
O	1987	1990	for
B-Symptom	1991	1992	H
I-Symptom	1992	1993	/
I-Symptom	1993	1995	Ma
O	1995	1996	,
O	1997	2009	respectively
O	2010	2011	(
O	2011	2012	P
O	2013	2014	<
O	2015	2016	0
O	2016	2017	.
O	2017	2021	0001
O	2021	2022	)
O	2022	2023	;
O	2024	2026	22
O	2026	2027	%
O	2027	2028	,
O	2029	2031	24
O	2031	2032	%
O	2032	2033	,
O	2034	2036	21
O	2036	2037	%
O	2037	2038	,
O	2039	2041	28
O	2041	2042	%
O	2042	2043	,
O	2044	2047	and
O	2048	2050	22
O	2050	2051	%
O	2052	2055	for
B-Symptom	2056	2058	VB
O	2058	2059	,
O	2060	2072	respectively
O	2073	2074	(
O	2074	2075	P
O	2076	2077	=
O	2078	2079	0
O	2079	2080	.
O	2080	2083	009
O	2083	2084	)
O	2084	2085	;
O	2086	2088	52
O	2088	2089	%
O	2089	2090	,
O	2091	2093	40
O	2093	2094	%
O	2094	2095	,
O	2096	2098	29
O	2098	2099	%
O	2099	2100	,
O	2101	2103	47
O	2103	2104	%
O	2104	2105	,
O	2106	2109	and
O	2110	2112	36
O	2112	2113	%
O	2114	2117	for
B-Symptom	2118	2122	IRMA
O	2122	2123	,
O	2124	2136	respectively
O	2137	2138	(
O	2138	2139	P
O	2140	2141	<
O	2142	2143	0
O	2143	2144	.
O	2144	2148	0001
O	2148	2149	)
O	2149	2150	,
O	2151	2154	and
O	2155	2156	8
O	2156	2157	%
O	2157	2158	,
O	2159	2160	4
O	2160	2161	%
O	2161	2162	,
O	2163	2164	4
O	2164	2165	%
O	2165	2166	,
O	2167	2168	8
O	2168	2169	%
O	2169	2170	,
O	2171	2174	and
O	2175	2176	5
O	2176	2177	%
O	2178	2181	for
B-Symptom	2182	2185	NVE
O	2185	2186	,
O	2187	2199	respectively
O	2200	2201	(
O	2201	2202	P
O	2203	2204	=
O	2205	2206	0
O	2206	2207	.
O	2207	2209	03
O	2209	2210	)
O	2210	2211	.

O	2212	2215	All
O	2216	2223	lesions
O	2224	2228	were
O	2229	2233	more
O	2234	2242	frequent
O	2243	2245	in
O	2246	2249	the
B-Anatomy	2250	2258	temporal
I-Anatomy	2259	2265	fields
O	2266	2274	compared
O	2275	2279	with
O	2280	2283	the
B-Anatomy	2284	2289	nasal
I-Anatomy	2290	2296	fields
O	2297	2298	(
O	2298	2299	P
O	2300	2301	<
O	2302	2303	0
O	2303	2304	.
O	2304	2308	0001
O	2308	2309	)
O	2309	2310	.

B-Diagnostic_tool	2311	2319	DiSLO200
I-Diagnostic_tool	2320	2326	images
O	2327	2330	had
O	2331	2342	substantial
O	2343	2352	agreement
O	2353	2357	with
B-Diagnostic_tool	2358	2363	ETDRS
I-Diagnostic_tool	2364	2368	film
I-Diagnostic_tool	2369	2380	photographs
O	2381	2384	and
B-Diagnostic_tool	2385	2388	DFE
O	2389	2391	in
O	2392	2403	determining
B-Disease	2404	2406	DR
O	2407	2415	severity
O	2415	2416	.

O	2417	2419	On
O	2420	2423	the
O	2424	2429	basis
O	2430	2432	of
B-Diagnostic_tool	2433	2441	DiSLO200
I-Diagnostic_tool	2442	2448	images
O	2448	2449	,
O	2450	2461	significant
O	2462	2472	nonuniform
O	2473	2485	distribution
O	2486	2488	of
B-Symptom	2489	2491	DR
I-Symptom	2492	2499	lesions
O	2500	2503	was
O	2504	2511	evident
O	2512	2518	across
O	2519	2522	the
B-Anatomy	2523	2529	retina
O	2529	2530	.

O	2531	2534	The
O	2535	2545	additional
B-Symptom	2546	2556	peripheral
I-Symptom	2557	2564	lesions
O	2565	2575	identified
O	2576	2578	by
B-Diagnostic_tool	2579	2587	DiSLO200
O	2588	2590	in
O	2591	2595	this
O	2596	2602	cohort
O	2603	2612	suggested
O	2613	2614	a
O	2615	2619	more
O	2620	2626	severe
O	2627	2637	assessment
O	2638	2640	of
B-Disease	2641	2643	DR
O	2644	2646	in
O	2647	2649	10
O	2649	2650	%
O	2651	2653	of
B-Anatomy	2654	2658	eyes
O	2659	2663	than
O	2664	2667	was
O	2668	2677	suggested
O	2678	2680	by
O	2681	2684	the
O	2685	2692	lesions
O	2693	2699	within
O	2700	2703	the
O	2704	2709	ETDRS
O	2710	2716	fields
O	2716	2717	.

O	2718	2725	However
O	2725	2726	,
O	2727	2730	the
O	2731	2743	implications
O	2744	2746	of
B-Symptom	2747	2757	peripheral
I-Symptom	2758	2765	lesions
O	2766	2768	on
B-Characteristic	2769	2771	DR
I-Characteristic	2772	2783	progression
O	2784	2790	within
O	2791	2792	a
O	2793	2801	specific
B-Characteristic	2802	2807	ETDRS
I-Characteristic	2808	2816	severity
O	2817	2822	level
O	2823	2827	over
O	2828	2832	time
O	2833	2836	are
O	2837	2844	unknown
O	2845	2848	and
O	2849	2853	need
O	2854	2856	to
O	2857	2859	be
O	2860	2869	evaluated
O	2870	2883	prospectively
O	2883	2884	.
